Sodium–Glucose Cotransporter-2 Inhibitors and Prevention of Adverse Kidney Outcomes in Type 2 Diabetes: A Clinical Multiethnic Asian Cohort
SGLT2 inhibitors significantly benefit kidney outcomes in multiethnic Asians with type 2 diabetes, highlighting their role in preventing kidney complications.
Authors
- Yong Mong Bee (ORCID: https://orcid.org/0000-0002-5482-2646)
- Liang Feng (ORCID: https://orcid.org/0000-0002-0252-0136)
- Tazeen H. Jafar (ORCID: https://orcid.org/0000-0001-7454-8376)
- Zhong Hong Liew (ORCID: https://orcid.org/0000-0002-7943-1510)
Institutions
- Singapore General Hospital (SG)
- Duke-NUS Medical School (SG)
Publication Details
- Journal
- Kidney Medicine
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1016/j.xkme.2024.100963
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- Singapore General Hospital